Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials.
S K Kumanyika, E Obarzanek, V J Stevens...
https://pubmed.ncbi.nlm.nih.gov/2031498Completed
Phase 3
Age: 30Years - 54Years
All Genders
ID00000528
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-03-16
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine if nonpharmacological interventions, including diet and lifestyle change, could prevent increases in arterial blood pressure leading to systemic hypertension.
CONDITIONS
Official Title
Trials of Hypertension Prevention (TOHP)
Who Can Participate
Age: 30Years - 54Years
All Genders
Eligibility Criteria
You may qualify if you...
Men and women, ages 30 to 54, with high normal diastolic blood pressure between 83 and 89 mm Hg.
Subjects were mildly obese.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
N/A
Model
FACTORIAL
Primary Purpose
PREVENTION
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Judging the effectiveness of antihypertensive therapy in an individual patient.
B Rosner, H G Langford
https://pubmed.ncbi.nlm.nih.gov/1941036Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention.
P K Whelton, P R Hebert, J Cutler...
https://pubmed.ncbi.nlm.nih.gov/1342280The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.
https://pubmed.ncbi.nlm.nih.gov/1586398Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group.
S K Kumanyika, P R Hebert, J A Cutler...
https://pubmed.ncbi.nlm.nih.gov/8406655Recruitment for phase I of the trials of hypertension prevention.
S Satterfield, N O Borhani, P Whelton...
https://pubmed.ncbi.nlm.nih.gov/8398224Screening rules for determining blood pressure status in clinical trials. Application to the trials of hypertension prevention.
N R Cook, B A Rosner
https://pubmed.ncbi.nlm.nih.gov/8333415Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group.
V J Stevens, S A Corrigan, E Obarzanek...
https://pubmed.ncbi.nlm.nih.gov/8466377Validity of 24-hour dietary recall interviews conducted among volunteers in an adult working community.
H A Kahn, P K Whelton, L J Appel...
https://pubmed.ncbi.nlm.nih.gov/8680612Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
L J Appel, P R Hebert, J D Cohen...
https://pubmed.ncbi.nlm.nih.gov/7795833